Key statistics
As of last trade Calidi Biotherapeutics Inc (CLDI:ASQ) traded at 1.10, 8.89% above its 52-week low of 1.01, set on Aug 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.10 |
---|---|
High | 1.10 |
Low | 1.09 |
Bid | 1.09 |
Offer | 1.10 |
Previous close | 1.09 |
Average volume | 54.78k |
---|---|
Shares outstanding | 8.08m |
Free float | 6.03m |
P/E (TTM) | -- |
Market cap | 8.81m USD |
EPS (TTM) | -5.41 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 15:02 BST.
More ▼
- Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
- Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor
- Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
- Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board